Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT04950426. We help you review the study, but cannot decide medical eligibility.
CompletedNCT04950426
Impact of PTSD Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome
This study is completed. It focuses on PTSD and currently lists study information in France.
PTSD, Fibromyalgia SyndromeDrugOver 18 Years
Understand this study
Who could participate?
Listed age limits: from 18 years.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: August 13, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 17
- Sponsor
- Centre Hospitalier Henri Laborit
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- France
- Age range
- Over 18 Years
- Official registry ID
- NCT04950426
- Official title
- Impact of Post-Traumatic Stress Disorder Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome
Recruitment & locations
CompletedPoitiers, France · Thouars, France
Compensation and expense reimbursement have not been verified for this summary.
Questions about this study
Who is behind this study?
The study sponsor is Centre Hospitalier Henri Laborit.
Does this study involve medication?
Yes. The study involves medication, including Propranolol.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as completed.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT03045016
Efficacy of Prazosin in Preventing PTSD
This study is completed. It focuses on PTSD and currently lists study information in France.
CompletedNCT00465608
Propranolol in PTSD
This study is completed. It focuses on PTSD and currently lists study information in France.
CompletedEUCTR 2020-005956-39
Treatment of pediatric Post-traumatic Stress Disorder with memory reactivation under the influence of propranolol: A randomized placebo-controlled trial
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.